{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:02:31Z","timestamp":1746417751163,"version":"3.40.4"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hubei Health Bureau","award":["20190533B16"],"award-info":[{"award-number":["20190533B16"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Although there are many studies showing potential benefit in aortic stenosis (AS) patients taking angiotensin-converting enzyme inhibitors (ACEI), but these studies are subject to significant selection and other biases, making the results challenging to interpret. Furthermore, the evidence on the use of ACEI in AS patients has not been reviewed systematically; we thus conducted this protocol assess the clinical effectiveness and safety of ACEI for patients with AS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The following search terms will be used in PUBMED, Scopus, EMBASE, and Cochrane Library databases on May, 2021, as the search algorithm: (angiotensin-converting enzyme inhibitors) OR (ACEI) AND (aortic stenosis) OR (AS). Two searchers will independently draft and carry out the search strategy, and the third member will further complete it. The studies on cohort study focusing on assessing the efficacy of ACEI on AS patients will be included in our meta-analysis. At least one of the following outcomes should have been measured: left ventricular mass, exercise tolerance, B-type natriuretic peptide, adverse event, functional outcomes, and aortic valve area. All outcomes are pooled on random-effect model. A <jats:italic toggle=\"yes\">P<\/jats:italic> value of &lt;.05 is considered to be statistically significant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The results of this research will be delivered in a peer-reviewed journal.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Depending on the previous studies, we assumed that ACEI could possibly improve the clinical symptoms and outcomes of symptomatic AS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Systematic review registration number:<\/jats:title>\n            <jats:p>10.17605\/OSF.IO\/G9KPT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025537","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T22:07:09Z","timestamp":1618351629000},"page":"e25537","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Safety and efficacy of angiotensin-converting enzyme inhibitors in aortic stenosis"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7673-9552","authenticated-orcid":false,"given":"Chengsheng","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanjuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/eci.12169","article-title":"Impact of hypertension and renin-angiotensin system inhibitors in aortic stenosis","volume":"43","author":"Capoulade","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"e20717","DOI":"10.1097\/MD.0000000000020717","article-title":"Incidence, predictors, and outcome of prosthesis-patient mismatch after transcatheter aortic valve replacement: a meta-analysis","volume":"99","author":"He","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/eurheartj\/ehz769","article-title":"Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries","volume":"41","author":"Chen","year":"2020","journal-title":"Eur Heart J"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ijcard.2014.06.013","article-title":"Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis","volume":"175","author":"Bang","year":"2014","journal-title":"Int J Cardiol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1016\/j.ahj.2003.10.017","article-title":"Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS)","volume":"147","author":"Chockalingam","year":"2004","journal-title":"Am Heart J"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/01.CIR.0000140723.15274.53","article-title":"Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis","volume":"110","author":"Rosenhek","year":"2004","journal-title":"Circulation"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/ehjci\/jev043","article-title":"A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial)","volume":"16","author":"Bull","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"R8-20250504","first-page":"337","article-title":"The effect of angiotensin-converting enzyme inhibitors and statins on the progression of aortic sclerosis and mortality","volume":"21","author":"Ardehali","year":"2012","journal-title":"J Heart Valve Dis"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00380-010-0052-x","article-title":"Administration of angiotensin-converting enzyme inhibitors is associated with slow progression of mild aortic stenosis in Japanese patients","volume":"26","author":"Wakabayashi","year":"2011","journal-title":"Heart Vessels"},{"key":"R10-20250504","doi-asserted-by":"crossref","DOI":"10.1177\/2042533313484145","article-title":"An underused opportunity to introduce ACE inhibitors and influence prognosis: observational study of patients undergoing aortic surgery","volume":"4","author":"Muttardi","year":"2013","journal-title":"JRSM Short Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025537","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:46:37Z","timestamp":1746337597000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025537"}},"subtitle":["A protocol for systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,4,16]]},"references-count":10,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025537","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,4,16]]},"assertion":[{"value":"2021-03-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}